Introduction
Ebola, a fatal and infectious disease that has claimed thousands of lives, has unavoidably caught my attention. I chose to delve into the subject of Ebola because of the significant global health implications it presents and the fear it has instilled in the hearts of millions of people worldwide. Its devastating impact on West Africa in 2014 and the more recent outbreaks in the Democratic Republic of Congo have highlighted the need for a comprehensive understanding and global preparedness against this lethal disease. I believe Ebola is a crucial disease to learn more about because of its high mortality rate, rapid transmission, and the lack of a fully licensed treatment or vaccine.
Topic Overview
The Ebola virus causes Ebola, a member of the Filoviridae family. This virus has five distinct species, four of which are known to cause diseases in humans. The Ebola virus is a filamentous, enveloped, negative-strand RNA virus(Feldmann et al., 2020). The disease caused by this virus, Ebola Virus Disease (EVD), is often characterized by the sudden onset of fever, weakness, muscle pain, headaches, and sore throat, followed by vomiting, diarrhea, rash, impaired kidney and liver function, and in some cases, both internal and external bleeding.
The virus is primarily transmitted from wild animals to humans and spreads in the human population through human-to-human transmission. It was first identified in 1976 in two simultaneous outbreaks in South Sudan and the Democratic Republic of Congo. The latter occurred in a village near the Ebola River, from which the disease takes its name. The 2014–2016 outbreak in West Africa was the largest and most complex Ebola outbreak since the virus was first discovered(Jacob et al., 2020). It resulted in more than 11,000 deaths and highlighted the need for a coordinated international response and improved national health systems.
Research Directions and Significance
Two significant questions that I hope to address in researching this disease are: How can we improve our level of preparedness and response to Ebola outbreaks? Are there promising treatments or vaccines on the horizon?
The global impact of the 2014–2016 Ebola outbreak demonstrated the need for improved preparedness and response to such disease outbreaks. Therefore, it is crucial to study the strategies and interventions that have been successful in controlling the disease, as well as the challenges and gaps that have been encountered (Feldmann et al., 2020). Understanding these aspects can guide future responses to Ebola outbreaks and other similar public health emergencies.
Additionally, despite the high fatality rate of Ebola, there is currently no fully licensed treatment or vaccine available. However, several potential therapies and vaccines are under development and have shown promise in clinical trials. Investigating these potential treatments and the challenges associated with their development and deployment can provide valuable insights into how to expedite the process of developing effective treatments and vaccines for Ebola and similar infectious diseases. Developing a treatment or vaccine for a disease like Ebola is a complex process that involves multiple stages, including preclinical testing, clinical trials, regulatory approval, and large-scale production and distribution (Jacob et al., 2020). Each stage presents unique challenges that can delay the development and deployment of effective treatments and vaccines.
Conclusion
In summary, Ebola is a serious illness that warrants greater public awareness due to its high fatality rate, swift spread, and the absence of a fully approved treatment or vaccine. The disease is caused by the Ebola virus, which is a filamentous, enveloped, negative-sense RNA virus. Research into this disease can answer essential questions about how to improve our preparedness and response to Ebola outbreaks, as well as the potential treatments or vaccines on the horizon.
References
Feldmann, H., Sprecher, A., & Geisbert, T. W. (2020). Ebola. New England Journal of Medicine, 382(19), 1832-1842.
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M. A. D. L., & Kuhn, J. H. (2020). Ebola virus disease. Nature Reviews Disease Primers, 6(1), 13.